Drug Search Results
More Filters [+]

Floxuridine

Alternative Names: floxuridine, fluorodeoxyuridine, fudr
Latest Update: 2024-12-04
Latest Update Note: Clinical Trial Update

Product Description

Floxuridine (FUDR) is a pyrimidine analogue used as an antineoplastic agent, usually as a continuous hepatic arterial infusion to treat hepatic metastases from colon cancer. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Floxuridine)

Mechanisms of Action: DNA Synthesis Inhibitor,TS Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Oral,Subcutaneous

FDA Designation: None *

Approval Status: Approved

Approved Countries: Italy | United States

Approved Indications: None

Known Adverse Events: None

Company: Jazz
Company Location: DUBLIN L2 4
Company CEO: Bruce C. Cozadd
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Floxuridine

Countries in Clinic: China

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Oncology Solid Tumor Unspecified

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

LY01616/CT-CHN-101

P2

Enrolling by invitation

Oncology Solid Tumor Unspecified

2024-08-31

57%

Recent News Events